Jim Simons
VCNX

Jim Simons’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Jim Simons’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,293
Closed -$21K – 4171
2023
Q4 		$21K Buy
+2,293
New +$27.1K ﹤0.01% 3576
2023
Q3 		– Sell
-220
Closed -$16K – 4210
2023
Q2 		$16K Buy
+220
New +$18.3K ﹤0.01% 3801

Other funds holding VCNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jim Simons's VCNX Position: Q1 2024 in Review

Jim Simons sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2024, closing a stake of 2,293 shares — an estimated $21K sold.

Jim Simons first reported a position in VCNX in Q2 2023 and held it in 2 quarters. The position peaked at $21K in Q4 2023. 12 funds tracked by Wall St. Rank hold VCNX as of Q1 2024.

  • Jim Simons reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jim Simons sold 2,293 Vaccinex, Inc. Common Stock shares in Q1 2024, an estimated $21K.
  • Jim Simons first reported a position in Vaccinex, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Jim Simons's Vaccinex, Inc. Common Stock position peaked at $21K in Q4 2023.
  • 12 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.